Deepali Eksambe
Neurology with Special Qualifications in Child Neurology · Phoenix, AZNPI 1982946299
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by UCB, Inc. at 25.7% of the total. 2025 is the largest year on record at $499, more than ten times the $31 reported in 2019.
Across 75 payments — averaging $21.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$420
- Jazz Pharmaceuticals Inc.$244
- Neurelis, Inc.$166
- Acadia Pharmaceuticals Inc$155
- SK Life Science, Inc.$102
- Biocodex, Inc.$83
- plus $463 from 15 others
What the payments were for
- Food & beverage$1,635100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 24 | $420 |
| Jazz Pharmaceuticals Inc. | 5 | $244 |
| Neurelis, Inc. | 7 | $166 |
| Acadia Pharmaceuticals Inc | 6 | $155 |
| SK Life Science, Inc. | 3 | $102 |
| Biocodex, Inc. | 3 | $83 |
| Greenwich Biosciences, Inc. | 5 | $70 |
| Sunovion Pharmaceuticals Inc. | 6 | $67 |
| Sobi, Inc | 2 | $49 |
| Livanova USA, Inc. | 2 | $43 |
| PTC Therapeutics, Inc. | 1 | $32 |
| ITF Therapeutics LLC | 1 | $32 |
| Eisai Inc. | 2 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Catalyst Pharmaceuticals, Inc. | 1 | $21 |
| Merck | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Biomarin Pharmaceutical Inc. | 1 | $17 |
| Metacel Pharmaceuticals LLC | 1 | $15 |
| Aquestive Therapeutics, Inc. | 1 | $15 |
| Aucta Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Epidiolex$121
How this compares
$1,635 in reported general payments places this provider in the 55th percentile of 49 neurology with special qualifications in child neurology providers in Arizona.
See all neurology with special qualifications in child neurology providers in Arizona →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clorazepate Dipotassium | 15 | $1,119 |
| Baclofen | 30 | $532 |
| Levetiracetam | 15 | $319 |
| Lamotrigine | 11 | $301 |
| Valproic AcidValproic Acid (As Sodium Salt) | 15 | $175 |
| Clonazepam | 11 | $135 |
| Trihexyphenidyl Hcl | 13 | $99 |
| Phenobarbital | 12 | $42 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Phoenix
- Angus WilfongPhoenix$348K
- Clara ChowPhoenix$35K
- Saunder BernesPhoenix$27K
- Randa JarrarPhoenix$25K
- Jeffrey BuchhalterPhoenix$19K
- Korwyn WilliamsPhoenix$13K
- Harlori BainsPhoenix$12K
- Tamara ZachPhoenix$10K
- Javier CardenasPhoenix$6K
- Vinodh NarayananPhoenix$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.